Ribonova
0 followers
‌
RiboNova is a privately-held biopharmaceutical company based in the Lankenau Institute for Medical Research near Philadelphia, Pennsylvania. Their product pipeline includes a Phase-2 ready small molecule drug for the treatment of all forms of genetically-confirmed mitochondrial disease.
Industries
Headquarters
Employees
Links
Org chart
Nigel L. Webb
President, CEO & Board Member
Nigel L. Webb
Collapse
Yucynthia A. Jean-Louis
Chief Business Officer
Anthony W. Ford-Hutchinson
Chief Scientific Officer & Board Member
Jane Hollingsworth
Member Board Of Directors
